Adaptive Biotechnologies Corporation Stock
Stocks
ADPT
US00650F1093
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
08:00:00 18/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 28.49 USD | +2.22% |
|
-5.85% | +75.43% |
| 16/11 | Adaptive Biotechnologies Insider Sold Shares Worth $1,047,303, According to a Recent SEC Filing | MT |
| 05/11 | Adaptive Biotechnologies Corporation, Q3 2026 Earnings Call, Nov 04, 2026 |
| Market Cap | 4.51B 4.1B 3.78B 3.41B 6.44B 422B 6.69B 45.59B 18.03B 227B 16.93B 16.57B 719B | P/E 2026 * |
-71.9x | P/E 2027 * | -589x |
|---|---|---|---|---|---|
| Enterprise Value | 4.27B 3.88B 3.58B 3.23B 6.1B 399B 6.34B 43.19B 17.08B 215B 16.04B 15.7B 681B | EV / Sales 2026 * |
13.9x | EV / Sales 2027 * | 11.4x |
| Free-Float |
97.19% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ADPT | Delayed | |
| ADPT | Real-time | ||
| 1HM | Real-time | ||
| 1HM | Real-time | ||
| 1HM | Delayed | ||
| 1HM | Delayed |
Last Transcript: Adaptive Biotechnologies Corporation
| 1 day | +2.22% | ||
| 1 week | -5.85% | ||
| Current month | +6.94% | ||
| 1 month | +18.61% | ||
| 3 months | +15.16% | ||
| 6 months | +122.06% | ||
| Current year | +75.43% |
| 1 week | 27.29 | 32.21 | |
| 1 month | 23.82 | 32.21 | |
| Current year | 12 | 32.21 | |
| 1 year | 12 | 32.21 | |
| 3 years | 2.28 | 32.21 | |
| 5 years | 2.28 | 32.21 | |
| 10 years | 2.28 | 71.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chad Robins
CEO | Chief Executive Officer | 51 | 08/09/2009 |
Kyle Piskel
DFI | Director of Finance/CFO | 42 | 08/04/2024 |
Julie Rubinstein
PSD | President | 54 | 01/02/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Chad Robins
CHM | Chairman | 51 | - |
Robert Hershberg
BRD | Director/Board Member | 63 | 01/02/2013 |
Peter Neupert
BRD | Director/Board Member | 70 | 01/12/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/11/26 | Exercice | Chairperson | 35,643 | 0.0223% | ||
| 29/10/26 | Exercice | Chairperson | 35,643 | 0.0223% | ||
| 26/10/26 | Exercice | Chairperson | 35,643 | 0.0223% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.22% | -5.85% | +102.06% | +606.95% | 4.51B | ||
| +1.15% | -2.81% | +53.73% | +71.00% | 65.56B | ||
| -2.64% | +0.07% | +9.57% | +89.87% | 60.41B | ||
| -1.07% | +0.55% | +21.79% | +87.66% | 55.76B | ||
| +0.48% | -0.98% | +12.97% | +118.46% | 46.98B | ||
| -2.69% | -7.62% | +16.77% | +25.79% | 43.63B | ||
| -0.70% | +1.43% | +14.05% | +45.20% | 36.7B | ||
| -2.50% | -18.72% | +140.13% | +665.60% | 36.09B | ||
| -0.77% | -4.34% | +79.27% | +59.47% | 32.9B | ||
| -0.83% | +4.96% | -36.93% | +398.61% | 26.96B | ||
| Average | -0.74% | -2.32% | +41.34% | +216.86% | 41B | |
| Weighted average by Cap. | -0.96% | -1.55% | +34.92% | +153.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 307M 279M 257M 232M 438M 28.69B 455M 3.1B 1.23B 15.48B 1.15B 1.13B 48.91B | 373M 339M 313M 282M 533M 34.88B 554M 3.77B 1.49B 18.82B 1.4B 1.37B 59.47B |
| Net income | -63.71M -57.84M -53.43M -48.2M -91M -5.95B -94.48M -644M -255M -3.21B -239M -234M -10.15B | -8.3M -7.53M -6.96M -6.28M -11.85M -775M -12.3M -83.83M -33.16M -418M -31.12M -30.47M -1.32B |
| Net Debt | -238M -216M -199M -180M -339M -22.2B -352M -2.4B -950M -11.98B -892M -873M -37.85B | -266M -242M -223M -202M -381M -24.9B -395M -2.69B -1.07B -13.44B -1B -979M -42.45B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/11/26 | USD 28.49 | +2.22% | 1,885,940 |
| 16/11/26 | USD 27.87 | -4.03% | 2,657,890 |
| 13/11/26 | USD 29.04 | -1.49% | 2,063,762 |
| 12/11/26 | USD 29.48 | -1.54% | 1,920,480 |
| 11/11/26 | USD 29.94 | +1.98% | 2,645,755 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- ADPT Stock
Select your edition
All financial news and data tailored to specific country editions
















